All‐Cause Unplanned Readmissions in the United States. Insights from the Nationwide Readmission Database

2021 ◽  
Author(s):  
Amod Amritphale ◽  
Gregg C. Fonarow ◽  
Nupur Amritphale ◽  
Bassam Omar ◽  
Errol D. Crook
2019 ◽  
Vol 123 (8) ◽  
pp. 1343-1350 ◽  
Author(s):  
Chun Shing Kwok ◽  
Purvi J. Parwani ◽  
David L. Fischman ◽  
Ritu Thamman ◽  
Jassim al Suwaidi ◽  
...  

2020 ◽  
Vol 165 ◽  
pp. 106346
Author(s):  
Monica B. Dhakar ◽  
David J. Thurman ◽  
Hiba A. Haider ◽  
Andres R. Rodriguez ◽  
Nathalie Jette ◽  
...  

2018 ◽  
Vol 154 (6) ◽  
pp. S-63-S-65
Author(s):  
Anwar Dudekula ◽  
Arkady Broder ◽  
Sugirdhana Velpari ◽  
Debra Goldstein ◽  
Srikaran Kalahasti ◽  
...  

Author(s):  
A. Hakam ◽  
J.T. Gau ◽  
M.L. Grove ◽  
B.A. Evans ◽  
M. Shuman ◽  
...  

Prostate adenocarcinoma is the most common malignant tumor of men in the United States and is the third leading cause of death in men. Despite attempts at early detection, there will be 244,000 new cases and 44,000 deaths from the disease in the United States in 1995. Therapeutic progress against this disease is hindered by an incomplete understanding of prostate epithelial cell biology, the availability of human tissues for in vitro experimentation, slow dissemination of information between prostate cancer research teams and the increasing pressure to “ stretch” research dollars at the same time staff reductions are occurring.To meet these challenges, we have used the correlative microscopy (CM) and client/server (C/S) computing to increase productivity while decreasing costs. Critical elements of our program are as follows:1) Establishing the Western Pennsylvania Genitourinary (GU) Tissue Bank which includes >100 prostates from patients with prostate adenocarcinoma as well as >20 normal prostates from transplant organ donors.


Sign in / Sign up

Export Citation Format

Share Document